GPT Healthcare Limited
CLOSEDIPO Date: 22 Feb - 26 Feb 2024
Listing Date: 29 Feb 2024
Price Range
₹177 to ₹186 per share
Issue Size
525.14 Cr
Min Investment
₹14,160
Lot Size
80 Shares
Schedule of GPT Healthcare Limited
Issue open date
22 Feb 2024
Issue close date
26 Feb 2024
UPI mandate deadline
26 Feb 2024 (5 PM)
Allotment finalization
27 Feb 2024
Share credit
28 Feb 2024
Listing date
29 Feb 2024
Mandate end date
13 Mar 2024
Issue size
| Funds Raised in the IPO | Amount |
|---|---|
| Overall | 525.14 Cr |
| Fresh Issue | Cr |
| Offer for Sale | Cr |
Allotment DetailsNew
| Allotment Timeline | Details |
|---|---|
| Allotment Date | 27 Feb 2024 |
| Allotment Link | {Link} |
Grey Market PremiumNew
Grey Market Premium (GMP) is the premium at which the shares are traded in the grey market. It gives a fair idea about the listing price of the IPO shares. The GMP can be positive or negative based on the demand and supply of the shares in the grey market.
| Date | Ipo Price | GMP | Estimated Listing Price |
|---|---|---|---|
| 29 Feb 2024 | ₹186 | ₹17 | ₹203 (9.14%) |
| 28 Feb 2024 | ₹186 | ₹17 | ₹203 (9.14%) |
| 27 Feb 2024 | ₹186 | ₹15 | ₹201 (8.06%) |
| 26 Feb 2024 | ₹186 | ₹14 | ₹200 (7.53%) |
| 25 Feb 2024 | ₹186 | ₹9 | ₹195 (4.84%) |
| 24 Feb 2024 | ₹186 | ₹10 | ₹196 (5.38%) |
| 23 Feb 2024 | ₹186 | ₹15 | ₹201 (8.06%) |
| 22 Feb 2024 | ₹186 | ₹19 | ₹205 (10.22%) |
Performance GPT Healthcare Limited
| Issue Price | Listing Gain | Current Market Price | P/L |
|---|---|---|---|
| ₹177 to ₹186 per share | ₹ 559 (7.9%) | ₹ 135.26 | -27.28% |
About GPT Healthcare Limited
Incorporated in 1989, GPT Healthcare Limited operates a chain of mid-sized, multi-specialty, full-service hospitals in Eastern India under the ILS Hospitals brand, providing integrated healthcare services focusing on secondary and tertiary care.Based in Kolkata, West Bengal, the company offers a range of healthcare services in over 35 specialties and super-specialties, including internal medicine and diabetology, nephrology (including kidney transplant), laparoscopic and general surgery, gynaecology and obstetrics, intensive care, gastroenterology, orthopaedics and joint replacement, interventional cardiology, neurology, neurosurgery, paediatrics, and neonatology. It also offers integrated diagnostic services and pharmacies.
| Founded in | 1989 |
| Managing director | |
| Parent organization |
Financial Overview
Strengths
Risks
Subscription Figures
| Category | Subscription (No. of times) |
|---|---|
| Qualified Institutional Buyers (QIBs) | 17.3 |
| Non-Institutional Investors (NIIs) | 11.02 |
| Retail Individual Investors (RIIs) | 2.44 |
| Employee | N/A |
| Total | 8.52 |